Cefaclor Anhydrous

Cefaclor Anhydrous

SCHEMBL2884379

N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1.O.O.O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Cefaclor Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 1.00
▸ HSD17B10 Q99714 7/20 1.00
▸ KDM4E B2RXH2 5/20 1.00
▸ CYP2C9 P11712 2/20 1.00
▸ MAPT P10636 7/20 0.98
▸ KMT2A Q03164 6/20 0.98
▸ MEN1 O00255 5/20 0.98
▸ CYP3A4 P08684 4/20 0.98
▸ HPGD P15428 3/20 0.98
▸ TDP1 Q9NUW8 3/20 0.98
▸ SLC15A2 Q16348 3/20 0.98
▸ LMNA P02545 2/20 0.98
▸ NR1I2 O75469 1/20 0.98
▸ ADORA3 P0DMS8 1/20 0.98
▸ CTDSP1 Q9GZU7 1/20 0.98
▸ HIF1A Q16665 1/20 0.98
▸ CYP2C19 P33261 2/20 0.76
▸ BLM P54132 1/20 0.76
▸ MAPK1 P28482 1/20 0.76
▸ ADRA1A P35348 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefaclor Anhydrous SCHEMBL28040138 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL956758 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL2370228 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL27866433 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL33539 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL23611123 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL9753635 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL33540 0.99 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL6155629 0.99 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT
Cefaclor Anhydrous SCHEMBL8626211 0.99 ALDH1A1 (1.00) ALDH1A1HSD17B10KDM4ECYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1180022-A4 PROCESS FOR PREPARING PHARMACEUTICAL BULK MATERIAL HAVING UNIFORM DISSOLUTION LILLY CO ELI (US) 2004-01-07 — — EP claimed
US-6596307-B1 Crystalline cefaclor with reduced water content ELI LILLY AND COMPANY 2003-07-22 — — US claimed
EP-1180022-A1 PROCESS FOR PREPARING PHARMACEUTICAL BULK MATERIAL HAVING UNIFORM DISSOLUTION ELI LILLY AND COMPANY (US) 2002-02-20 — — EP claimed
WO-2000069417-A1 PROCESS FOR PREPARING PHARMACEUTICAL BULK MATERIAL HAVING UNIFORM DISSOLUTION ELI LILLY AND COMPANY (US) 2000-11-23 — — WO claimed
US-7663107-B2 Method and apparatus for quantitative analysis using terahertz radiation TERAVIEW LIMITED (GB) 2010-02-16 — — US disclosed
US-7244934-B2 Analysis apparatus and method TERAVIEW LIMITED (GB) 2007-07-17 — — US disclosed
US-20060237650-A1 Method and apparatus for quantitative analysis using terahertz radiation TERAVIEW LIMITED (GB) 2006-10-26 — — US disclosed
EP-1634064-A1 METHOD AND APPARATUS FOR QUANTITATIVE ANALYSIS USING TERAHERTZ RADIATION TeraView Limited (GB) 2006-03-15 — — EP disclosed
US-20050156120-A1 Analysis apparatus and method ETV CAPITAL S.A. (LU) 2005-07-21 — — US disclosed
WO-2004106905-A1 METHOD AND APPARATUS FOR QUANTITATIVE ANALYSIS USING TERAHERTZ RADIATION TERAVIEW LIMITED (GB) 2004-12-09 — — WO disclosed
EP-1474675-A2 AN ANALYSIS APPARATUS AND METHOD Teraview Limited (GB) 2004-11-10 — — EP disclosed
EP-1180022-A4 PROCESS FOR PREPARING PHARMACEUTICAL BULK MATERIAL HAVING UNIFORM DISSOLUTION LILLY CO ELI (US) 2004-01-07 — — EP disclosed
US-6596307-B1 Crystalline cefaclor with reduced water content ELI LILLY AND COMPANY 2003-07-22 — — US disclosed
US-6596307-B1 Crystalline cefaclor with reduced water content ELI LILLY AND COMPANY 2003-07-22 — — US disclosed
EP-1180022-A1 PROCESS FOR PREPARING PHARMACEUTICAL BULK MATERIAL HAVING UNIFORM DISSOLUTION ELI LILLY AND COMPANY (US) 2002-02-20 — — EP disclosed
EP-1180022-A1 PROCESS FOR PREPARING PHARMACEUTICAL BULK MATERIAL HAVING UNIFORM DISSOLUTION ELI LILLY AND COMPANY (US) 2002-02-20 — — EP disclosed
WO-2000069417-A1 PROCESS FOR PREPARING PHARMACEUTICAL BULK MATERIAL HAVING UNIFORM DISSOLUTION ELI LILLY AND COMPANY (US) 2000-11-23 — — WO disclosed
WO-2000069417-A1 PROCESS FOR PREPARING PHARMACEUTICAL BULK MATERIAL HAVING UNIFORM DISSOLUTION ELI LILLY AND COMPANY (US) 2000-11-23 — — WO disclosed
CN-1144274-A Improved enzymatic process for producing penicillins and cephalosporins ACS DOBFAR SPA (IT) 1997-03-05 — — CN disclosed
EP-0730035-A1 Improved enzymatic process for producing penicillins and cephalosporins ACS DOBFAR S.p.A. (IT) 1996-09-04 — — EP disclosed
Send feedback